Clinical trial
Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women With Early Stage Breast Cancer (PBI 3.0)
NCT01928589 is registered in ClinicalTrials.gov with Richard Zellars as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women With Early Stage Breast Cancer (PBI 3.0)
- Lead sponsor
- Richard Zellars
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 16, 2014
- Completion date
- December 31, 2028
- Enrollment
- 81 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma of the breast, breast cancer